Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore

Summary

Columvi is now available with subsidized access for eligible patients with relapsed or refractory DLBCL in Singapore. This represents a market access expansion in the Asia-Pacific region.